Literature DB >> 31159562

Calcimimetic R568 improved cardiac remodeling by classic and novel renin-angiotensin system in spontaneously hypertensive rats.

Tian Zhang1, Na Tang1, Dongmei Xi1, Yongli Zhao1, Yongmin Liu1, Lamei Wang2, Yan Tang3, Xiaoni Zhang4, Hua Zhong1, Fang He1.   

Abstract

Entities:  

Keywords:  Essential hypertension; NPSR568; calcium-sensing receptor; cardiac remodeling; renin-angiotensin system

Mesh：

Substances：

Year:  2019        PMID： 31159562      PMCID： PMC6643192          DOI： 10.1177/1535370219854325

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN： 1535-3699


× No keyword cloud information.
  43 in total

Review 1.  Proapoptotic multidomain Bcl-2/Bax-family proteins: mechanisms, physiological roles, and therapeutic opportunities.

Authors:  J C Reed
Journal:  Cell Death Differ       Date:  2006-06-02       Impact factor: 15.828

Review 2.  Extracellular calcium sensing and extracellular calcium signaling.

Authors:  E M Brown; R J MacLeod
Journal:  Physiol Rev       Date:  2001-01       Impact factor: 37.312

3.  Calcimimetic NPS R-568 induces hypotensive effect in spontaneously hypertensive rats.

Authors:  Apolonia Rybczyńska; Konrad Boblewski; Artur Lehmann; Czeslawa Orlewska; Henryk Foks; Krystyna Drewnowska; Anzelm Hoppe
Journal:  Am J Hypertens       Date:  2005-03       Impact factor: 2.689

Review 4.  Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.

Authors:  László Hunyady; Kevin J Catt
Journal:  Mol Endocrinol       Date:  2005-09-01

5.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

6.  Calcium receptor is functionally expressed in rat neonatal ventricular cardiomyocytes.

Authors:  Jacob Tfelt-Hansen; Jakob Lerche Hansen; Sanela Smajilovic; Ernest F Terwilliger; Stig Haunso; Soren P Sheikh
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-10-21       Impact factor: 4.733

Review 7.  International union of pharmacology. XXIII. The angiotensin II receptors.

Authors:  M de Gasparo; K J Catt; T Inagami; J W Wright; T Unger
Journal:  Pharmacol Rev       Date:  2000-09       Impact factor: 25.468

8.  Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors.

Authors:  Hiroaki Ogata; Eberhard Ritz; Giulio Odoni; Kerstin Amann; Stephan R Orth
Journal:  J Am Soc Nephrol       Date:  2003-04       Impact factor: 10.121

9.  Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

Authors:  Carlos M Ferrario; Jewell Jessup; Mark C Chappell; David B Averill; K Bridget Brosnihan; E Ann Tallant; Debra I Diz; Patricia E Gallagher
Journal:  Circulation       Date:  2005-05-16       Impact factor: 29.690

10.  Calcium and polyamine regulated calcium-sensing receptors in cardiac tissues.

Authors:  Rui Wang; Changqing Xu; Weimin Zhao; Jing Zhang; Kun Cao; Baofeng Yang; Lingyun Wu
Journal:  Eur J Biochem       Date:  2003-06
View more
  5 in total

1.  Comparative transcriptomic analysis revealed novel potential therapeutic targets of traditional Chinese medicine (Pinggan-Qianyang decoction) on vascular remodeling in spontaneously hypertensive rats.

Authors:  Jiamei Yao; Cui Zhang; Yushu Yang; Xia Fang; Qiong Chen; Guangwei Zhong
Journal:  Chin Med       Date:  2021-02-10       Impact factor: 5.455

2.  miR-1929-3p Overexpression Alleviates Murine Cytomegalovirus-Induced Hypertensive Myocardial Remodeling by Suppressing Ednra/NLRP3 Inflammasome Activation.

Authors:  YongJia Wang; Zhen Huang; Hua Zhong; LaMei Wang; DongMei Xi; YunZhong Shi; Wei Zhou; YongMin Liu; Na Tang; Fang He
Journal:  Biomed Res Int       Date:  2020-12-30       Impact factor: 3.411

Review 3.  Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease.

Authors:  Yi-Chou Hou; Cai-Mei Zheng; Hui-Wen Chiu; Wen-Chih Liu; Kuo-Cheng Lu; Chien-Lin Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-31

Review 4.  Calcium-Sensing Receptor (CaSR)-Mediated Intracellular Communication in Cardiovascular Diseases.

Authors:  Hezhen Chu; Zhenqian Qin; Jun Ma; Yimin Xie; Haifeng Shi; Jie Gu; Baiqiang Shi
Journal:  Cells       Date:  2022-09-30       Impact factor: 7.666

Review 5.  Calcium-Sensing Receptor (CaSR), Its Impact on Inflammation and the Consequences on Cardiovascular Health.

Authors:  Sai Sahana Sundararaman; Emiel P C van der Vorst
Journal:  Int J Mol Sci       Date:  2021-03-01       Impact factor: 5.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.